Press Releases 2017
The Boston Scientific LOTUS™ Valve System demonstrated superior efficacy to CoreValve® in global REPRISE III trial at one year - May 16, 2017
Boston Scientific (NYSE: BSX) today announced positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris. Data from the study demonstrated that...
Boston Scientific Closes Symetis Acquisition - May 16, 2017
Acquisition Expands Company’s Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease.